Eli Lilly offers higher Zepbound weight loss drug doses on LillyDirect

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without … Read more

FDA says Wegovy and Ozempic shortage resolved; Hims & Hers stock falls

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the U.S. Food and Drug Administration said Friday.  The FDA’s decision will threaten the … Read more

UnitedHealth faces DOJ investigation, buyouts, stock price drop

FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016.  Mike Blake | Reuters UnitedHealthcare is in hot water again as the insurance giant grapples with a reported government investigation of its Medicare billing practices, pursues employee buyouts and potential layoffs, and … Read more

Eli Lilly Dan Skovronsky discusses weight loss drugs

Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli Lilly, he’s already done it once with the company’s weekly shot, Zepbound. He’s trying to do it again with a more convenient daily pill, then repeat the feat with a shot that could be even more powerful than Zepbound. And … Read more

UnitedHealthcare offers buyouts, could pursue layoffs

A general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota.  Stephen Maturen | Getty Images UnitedHealthcare is offering certain employees in its benefits operations unit the option to accept buyouts if they quit by March 3, following a tumultuous year for the insurance giant, CNBC has learned. Those who … Read more

Ozempic helps curb alcohol use in new study

Steve Christo | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol.  That’s according to new government-funded research … Read more

Moderna (MRNA) Q4 earnings 2024

Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls.  It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline … Read more

CVS earnings: (CVS) stock rises

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada, on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images After a dismal 2024, CVS Health could be starting to turn itself around.  Some investors seem convinced, especially after the retail drugstore chain on … Read more